The world’s first CAR-T therapy for solid tumors, Kailimei® (CT041), has been approved in China for advanced gastric cancer. A milestone breakthrough, it marks China’s leap from follower to leader in solid tumor cell therapy. Jiahui International Cancer Center is among the first to offer this innovative treatment, bringing new hope to patients.

During the treatment, Dr. Chen Yan, Director of the Neurology Department at Jiahui, also addressed several Parkinson’s disease-related issues for Daniel: adjusting his medications, preventing fall risks and formulating a rehabilitation plan. These problems,which had never been properly managed during his treatment in the US, received meticulous attention at Jiahui.

🏥 Medical Guide for Foreigners Traveling in Beijing Visiting Beijing and worried about health emergencies? Here’s a data-backed guide ...